Global X HealthTech ETF (NASDAQ:HEAL) Sees Significant Decline in Short Interest

Posted by Teresa Graham on Feb 26th, 2026

Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) saw a large drop in short interest in the month of February. As of February 13th, there was short interest totaling 1,547 shares, a drop of 74.3% from the January 29th total of 6,028 shares. Based on an average trading volume of 19,205 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the shares of the company are short sold. Currently, 0.1% of the shares of the company are short sold. Based on an average trading volume of 19,205 shares, the short-interest ratio is currently 0.1 days.

Global X HealthTech ETF Stock Performance

Shares of HEAL stock opened at $26.40 on Thursday. Global X HealthTech ETF has a 52-week low of $24.48 and a 52-week high of $34.20. The stock has a market cap of $35.11 million, a price-to-earnings ratio of 42.80 and a beta of 1.13. The firm’s 50-day moving average is $28.75 and its 200-day moving average is $30.58.

Global X HealthTech ETF Dividend Announcement

The firm also recently disclosed a dividend, which was paid on Wednesday, January 7th. Shareholders of record on Tuesday, December 30th were paid a $0.0718 dividend. The ex-dividend date was Tuesday, December 30th.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Daiwa Securities Group Inc. acquired a new stake in Global X HealthTech ETF during the 3rd quarter valued at $11,239,000. WT Wealth Management lifted its stake in shares of Global X HealthTech ETF by 10.1% during the 4th quarter. WT Wealth Management now owns 88,171 shares of the company’s stock worth $2,576,000 after buying an additional 8,066 shares during the last quarter. Flow Traders U.S. LLC bought a new stake in shares of Global X HealthTech ETF during the 3rd quarter worth about $368,000. Raymond James Financial Inc. acquired a new position in Global X HealthTech ETF in the 3rd quarter valued at about $274,000. Finally, Citadel Advisors LLC bought a new position in Global X HealthTech ETF in the 3rd quarter valued at about $216,000.

About Global X HealthTech ETF

(Get Free Report)

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.